Alterola Biotech, Inc.
ABTI
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 460.30K | 663.70K | 256.80K | 1.11M | 123.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 477.20K | 682.80K | 282.60K | 1.11M | 123.20K |
| Operating Income | -477.20K | -682.80K | -282.60K | -1.11M | -123.20K |
| Income Before Tax | -799.20K | -654.70K | 296.00K | -1.82M | -123.20K |
| Income Tax Expenses | -- | -- | -194.80K | 194.80K | -- |
| Earnings from Continuing Operations | -799.20K | -654.70K | 490.80K | -2.01M | -123.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 107.40K | -- | -- | -- | -- |
| Net Income | -691.80K | -654.70K | 490.80K | -2.01M | -123.20K |
| EBIT | -477.20K | -682.80K | -282.60K | -1.11M | -123.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.47B | 1.43B | 1.36B | 1.27B | 800.11M |
| Average Diluted Shares Outstanding | 1.47B | 1.43B | 1.36B | 1.27B | 800.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |